OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment
Jee Soo Park, Myung Eun Lee, Won Sik Jang, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 173-173
Open Access | Times Cited: 8
Jee Soo Park, Myung Eun Lee, Won Sik Jang, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 173-173
Open Access | Times Cited: 8
Showing 8 citing articles:
PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma
Jee Soo Park, Myung Eun Lee, Jong Chan Kim, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Jee Soo Park, Myung Eun Lee, Jong Chan Kim, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy
Weilin Liu, Hongqi Chen, Zhi Zhu, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1425-1425
Open Access | Times Cited: 20
Weilin Liu, Hongqi Chen, Zhi Zhu, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1425-1425
Open Access | Times Cited: 20
Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies
Namhee Lee, Yun‐Hui Jeon, Jiyoon Yoo, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e006024-e006024
Open Access | Times Cited: 11
Namhee Lee, Yun‐Hui Jeon, Jiyoon Yoo, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e006024-e006024
Open Access | Times Cited: 11
Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy
Yun‐Hui Jeon, Namhee Lee, Jiyoon Yoo, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 805-805
Open Access | Times Cited: 8
Yun‐Hui Jeon, Namhee Lee, Jiyoon Yoo, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 805-805
Open Access | Times Cited: 8
Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models
Junjie Ye, Lingjuan Chen, Julia Waltermire, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1021-1021
Open Access | Times Cited: 1
Junjie Ye, Lingjuan Chen, Julia Waltermire, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1021-1021
Open Access | Times Cited: 1
Innovative strategies in genitourinary cancer: the role of oncolytic viruses
Jie Zhang, Kepu Liu, Zhu Zheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Jie Zhang, Kepu Liu, Zhu Zheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Synergistic anti-tumor effects of oncolytic virus and anti-programmed cell death protein 1 antibody combination therapy: For suppression of lymph node and distant metastasis in a murine melanoma model
Yuki Sasaki, Taku Maeda, Masahiro Hojo, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 740, pp. 151011-151011
Closed Access
Yuki Sasaki, Taku Maeda, Masahiro Hojo, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 740, pp. 151011-151011
Closed Access
Novel Targets in Development for Advanced Renal Cell Carcinoma
Bicky Thapa, Ariel Ann Nelson, Deepak Kilari
Springer eBooks (2023), pp. 309-342
Closed Access
Bicky Thapa, Ariel Ann Nelson, Deepak Kilari
Springer eBooks (2023), pp. 309-342
Closed Access
